Enhanced induction of fetal hemoglobin by the combination of decitabine with RN-1 in β-thalassemia/HbE erythroid progenitor cells

Abstract Background Fetal hemoglobin (HbF; α2γ2) induction is a well-established approach for β-hemoglobinopathies, including sickle cell disease (SCD) and β-thalassemia. Decitabine, a DNA methyltransferase 1 (DNMT1) inhibitor, has been shown to effectively induce HbF production with a favorable saf...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Tiwaporn Nualkaew, Phitchapa Pongpaksupasin, Thongperm Munkongdee, Nattrika Buasuwan, Kittiphong Paiboonsukwong, Orapan Sripichai, James Douglas Engel, Suradej Hongeng, Suthat Fucharoen, Natee Jearawiriyapaisarn
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2026-01-01
Serie:	Molecular Medicine
Soggetti:	Fetal hemoglobin induction β-thalassemia/HbE Decitabine RN-1 Combination treatment
Accesso online:	https://doi.org/10.1186/s10020-026-01421-8
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!